Portfolio Holdings Detail for ISIN IE00B3ZW0K18
Stock Name / Fund iShares S&P 500 EUR Hedged UCITS ETF (Acc)
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker IBCF(EUR) F
ETF Ticker IUES.AS(EUR) CXE
ETF Ticker IUSE.L(EUR) CXE
ETF Ticker IUSE.MI(EUR) CXE
ETF Ticker IUSEz(EUR) CXE
ETF Ticker IUSE(EUR) ETF Plus

Holdings detail for LLY

Stock Name	Eli Lilly and Company
Ticker	LLY(EUR) F
TYPE	Common Stock
Country	Germany
ISIN	US5324571083
LEI	FRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG: Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs: With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About: Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price: Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial: (RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY: The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today: Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock: Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years: Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever: Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years: Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?: Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!: My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks: In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?: Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies: Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats: Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble: Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years: Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade: Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way: Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly: In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis: Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.: Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now: Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks: Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?: Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy: In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares S&P 500 EUR Hedged UCITS ETF (Acc) LLY holdings

Date	Number of LLY Shares Held	Base Market Value of LLY Shares	Local Market Value of LLY Shares	Change in LLY Shares Held	Change in LLY Base Value	Current Price per LLY Share Held	Previous Price per LLY Share Held
2025-09-18 (Thursday)	125,036	USD 81,006,892	USD 81,006,892	0	USD 801,310	USD 647.869	USD 641.46
2025-09-17 (Wednesday)	125,036	USD 80,205,582	USD 80,205,582	0	USD -469,645	USD 641.46	USD 645.216
2025-09-16 (Tuesday)	125,036	USD 80,675,227	USD 80,675,227	179	USD 1,225,696	USD 645.216	USD 636.324
2025-09-15 (Monday)	124,857	USD 79,449,531	USD 79,449,531	179	USD -861,302	USD 636.324	USD 644.146
2025-09-12 (Friday)	124,678	USD 80,310,833	USD 80,310,833	0	USD -87,767	USD 644.146	USD 644.85
2025-09-11 (Thursday)	124,678	USD 80,398,600	USD 80,398,600	0	USD 173,051	USD 644.85	USD 643.462
2025-09-10 (Wednesday)	124,678	USD 80,225,549	USD 80,225,549
2025-09-09 (Tuesday)	124,320	USD 79,542,970	USD 79,542,970
2025-09-08 (Monday)	124,320	USD 78,184,525	USD 78,184,525

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE00B3ZW0K18

Show aggregate share trades of LLY

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-16 BUY 179 645.216* 722.28
2025-09-15 BUY 179 636.324* 722.73
2025-08-27 BUY 352 633.287* 724.03
2025-08-21 BUY 176 611.045* 725.96
2025-08-20 SELL -352 604.853* 726.62 Profit of 255,769 on sale
2025-08-13 BUY 352 563.582* 728.27
2025-08-12 BUY 176 548.467* 729.26
2025-08-08 SELL -176 536.762* 731.34 Profit of 128,715 on sale
2025-08-05 BUY 352 662.243* 732.23
2025-08-04 SELL -704 664.966* 732.61 Profit of 515,756 on sale
2025-08-01 SELL -176 659.769* 733.02 Profit of 129,012 on sale
2025-07-31 SELL -3,060 646.603* 733.52 Profit of 2,244,556 on sale
2025-07-30 BUY 181 662.091* 733.93
2025-07-18 SELL -543 662.554* 736.30 Profit of 399,813 on sale
2025-07-16 SELL -362 681.068* 737.11 Profit of 266,835 on sale
2025-07-10 BUY 181 676.897* 738.63
2025-07-07 BUY 362 658.406* 740.01
2025-07-02 BUY 181 662.231* 741.49
2025-06-24 BUY 352 669.777* 743.85
2025-06-23 BUY 176 668.349* 744.36
2025-06-18 BUY 176 682.131* 745.74
2025-06-17 BUY 176 686.423* 746.15
2025-06-05 SELL -352 668.278* 749.26 Profit of 263,738 on sale
2025-06-03 BUY 352 659.013* 750.50
2025-05-28 BUY 1,936 636.516* 753.73
2025-05-27 BUY 528 639.439* 754.60
2025-05-22 SELL -176 634.127* 757.52 Profit of 133,324 on sale
2025-05-21 SELL -176 639.229* 758.45 Profit of 133,488 on sale
2025-05-20 SELL -352 662.919* 759.21 Profit of 267,242 on sale
2025-05-19 SELL -352 671.000* 759.92 Profit of 267,490 on sale
2025-05-15 BUY 176 655.484* 761.42
2025-05-14 BUY 352 638.124* 762.43
2025-05-13 BUY 528 668.363* 763.21
2025-05-12 BUY 1,056 679.959* 763.91
2025-05-09 BUY 528 651.879* 764.85
2025-05-02 BUY 176 724.444* 767.85
2025-04-30 BUY 5,597 790.807* 768.22
2025-04-28 BUY 167 770.973* 768.11
2025-04-25 SELL -167 778.062* 768.01 Profit of 128,258 on sale
2025-04-24 BUY 501 755.906* 768.13
2025-04-23 BUY 167 730.767* 768.48
2025-04-22 BUY 167 720.979* 768.92
2025-04-16 SELL -167 645.640* 771.26 Profit of 128,801 on sale
2025-04-15 BUY 167 668.415* 772.28
2025-04-14 BUY 334 663.602* 773.37
2025-04-11 BUY 334 645.950* 774.65
2025-04-10 BUY 167 644.792* 775.98
2025-04-09 BUY 167 682.801* 776.94
2025-04-08 BUY 334 665.604* 778.10
2025-04-07 SELL -167 662.605* 779.32 Profit of 130,146 on sale
2025-04-04 SELL -1,002 671.802* 780.46 Profit of 782,021 on sale
2025-04-01 SELL -334 744.859* 781.14 Profit of 260,900 on sale
2025-03-31 BUY 3,465 764.590* 781.32
2025-03-28 SELL -322 759.965* 781.56 Profit of 251,661 on sale
2025-03-25 BUY 161 789.176* 781.88
2025-03-21 SELL -644 774.882* 781.73 Profit of 503,434 on sale
2025-03-20 SELL -483 776.777* 781.79 Profit of 377,604 on sale
2025-03-18 BUY 966 752.732* 782.29
2025-03-11 SELL -161 754.150* 784.41 Profit of 126,290 on sale
2025-03-10 SELL -486 765.638* 784.66 Profit of 381,344 on sale
2025-03-07 SELL -1,127 799.982* 784.45 Profit of 884,080 on sale
2025-03-05 SELL -483 863.731* 783.38 Profit of 378,374 on sale
2025-03-03 SELL -644 886.672* 780.81 Profit of 502,841 on sale
2025-02-27 SELL -161 869.260* 778.05 Profit of 125,267 on sale
2025-02-19 BUY 161 831.782* 771.73
2025-02-18 BUY 322 818.955* 770.98
2025-02-13 BUY 322 835.635* 768.79
2025-02-05 SELL -1,288 808.118* 761.30 Profit of 980,561 on sale
2025-02-04 BUY 161 795.790* 760.65
2025-01-31 BUY 523 780.222* 759.78
2025-01-29 BUY 161 771.670* 758.94
2025-01-28 BUY 161 772.210* 758.66
2025-01-24 BUY 483 746.729* 758.68
2025-01-23 BUY 1,127 737.293* 759.15
2025-01-22 BUY 805 723.624* 759.96
2025-01-21 BUY 161 713.764* 761.04
2025-01-16 BUY 966 735.498* 764.67
2025-01-15 BUY 161 724.603* 765.70
2025-01-10 BUY 161 780.428* 766.00
2024-12-10 BUY 165 761.179* 766.25
2024-12-09 BUY 660 758.667* 766.49
2024-12-05 SELL -330 780.839* 765.47 Profit of 252,606 on sale
2024-12-04 BUY 495 788.110* 764.69
2024-12-03 SELL -825 773.311* 764.38 Profit of 630,616 on sale
2024-12-02 BUY 330 763.933* 764.40
2024-11-29 SELL -3,232 753.030* 764.84 Profit of 2,471,953 on sale
2024-11-25 BUY 338 719.836* 769.11
2024-11-22 SELL -169 718.549* 771.52 Profit of 130,387 on sale
2024-11-21 SELL -169 713.462* 774.42 Profit of 130,877 on sale
2024-11-18 BUY 845 687.757* 787.96
2024-11-12 BUY 169 771.818* 788.97
2024-11-08 BUY 1,183 773.598* 790.58
2024-11-07 BUY 338 737.560* 794.65
2024-11-06 BUY 169 722.987* 800.63
2024-10-31 SELL -2,194 764.279* 826.17 Profit of 1,812,623 on sale
2024-10-29 BUY 174 836.764* 832.18
2024-10-28 BUY 174 827.832* 833.05
2024-10-25 BUY 174 824.170* 835.27
2024-10-24 BUY 174 825.487* 838.54
2024-10-23 SELL -348 838.283* 838.66 Profit of 291,855 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-16	BUY	179	645.216*	722.28
2025-09-15	BUY	179	636.324*	722.73
2025-08-27	BUY	352	633.287*	724.03
2025-08-21	BUY	176	611.045*	725.96
2025-08-20	SELL	-352	604.853*	726.62 Profit of 255,769 on sale
2025-08-13	BUY	352	563.582*	728.27
2025-08-12	BUY	176	548.467*	729.26
2025-08-08	SELL	-176	536.762*	731.34 Profit of 128,715 on sale
2025-08-05	BUY	352	662.243*	732.23
2025-08-04	SELL	-704	664.966*	732.61 Profit of 515,756 on sale
2025-08-01	SELL	-176	659.769*	733.02 Profit of 129,012 on sale
2025-07-31	SELL	-3,060	646.603*	733.52 Profit of 2,244,556 on sale
2025-07-30	BUY	181	662.091*	733.93
2025-07-18	SELL	-543	662.554*	736.30 Profit of 399,813 on sale
2025-07-16	SELL	-362	681.068*	737.11 Profit of 266,835 on sale
2025-07-10	BUY	181	676.897*	738.63
2025-07-07	BUY	362	658.406*	740.01
2025-07-02	BUY	181	662.231*	741.49
2025-06-24	BUY	352	669.777*	743.85
2025-06-23	BUY	176	668.349*	744.36
2025-06-18	BUY	176	682.131*	745.74
2025-06-17	BUY	176	686.423*	746.15
2025-06-05	SELL	-352	668.278*	749.26 Profit of 263,738 on sale
2025-06-03	BUY	352	659.013*	750.50
2025-05-28	BUY	1,936	636.516*	753.73
2025-05-27	BUY	528	639.439*	754.60
2025-05-22	SELL	-176	634.127*	757.52 Profit of 133,324 on sale
2025-05-21	SELL	-176	639.229*	758.45 Profit of 133,488 on sale
2025-05-20	SELL	-352	662.919*	759.21 Profit of 267,242 on sale
2025-05-19	SELL	-352	671.000*	759.92 Profit of 267,490 on sale
2025-05-15	BUY	176	655.484*	761.42
2025-05-14	BUY	352	638.124*	762.43
2025-05-13	BUY	528	668.363*	763.21
2025-05-12	BUY	1,056	679.959*	763.91
2025-05-09	BUY	528	651.879*	764.85
2025-05-02	BUY	176	724.444*	767.85
2025-04-30	BUY	5,597	790.807*	768.22
2025-04-28	BUY	167	770.973*	768.11
2025-04-25	SELL	-167	778.062*	768.01 Profit of 128,258 on sale
2025-04-24	BUY	501	755.906*	768.13
2025-04-23	BUY	167	730.767*	768.48
2025-04-22	BUY	167	720.979*	768.92
2025-04-16	SELL	-167	645.640*	771.26 Profit of 128,801 on sale
2025-04-15	BUY	167	668.415*	772.28
2025-04-14	BUY	334	663.602*	773.37
2025-04-11	BUY	334	645.950*	774.65
2025-04-10	BUY	167	644.792*	775.98
2025-04-09	BUY	167	682.801*	776.94
2025-04-08	BUY	334	665.604*	778.10
2025-04-07	SELL	-167	662.605*	779.32 Profit of 130,146 on sale
2025-04-04	SELL	-1,002	671.802*	780.46 Profit of 782,021 on sale
2025-04-01	SELL	-334	744.859*	781.14 Profit of 260,900 on sale
2025-03-31	BUY	3,465	764.590*	781.32
2025-03-28	SELL	-322	759.965*	781.56 Profit of 251,661 on sale
2025-03-25	BUY	161	789.176*	781.88
2025-03-21	SELL	-644	774.882*	781.73 Profit of 503,434 on sale
2025-03-20	SELL	-483	776.777*	781.79 Profit of 377,604 on sale
2025-03-18	BUY	966	752.732*	782.29
2025-03-11	SELL	-161	754.150*	784.41 Profit of 126,290 on sale
2025-03-10	SELL	-486	765.638*	784.66 Profit of 381,344 on sale
2025-03-07	SELL	-1,127	799.982*	784.45 Profit of 884,080 on sale
2025-03-05	SELL	-483	863.731*	783.38 Profit of 378,374 on sale
2025-03-03	SELL	-644	886.672*	780.81 Profit of 502,841 on sale
2025-02-27	SELL	-161	869.260*	778.05 Profit of 125,267 on sale
2025-02-19	BUY	161	831.782*	771.73
2025-02-18	BUY	322	818.955*	770.98
2025-02-13	BUY	322	835.635*	768.79
2025-02-05	SELL	-1,288	808.118*	761.30 Profit of 980,561 on sale
2025-02-04	BUY	161	795.790*	760.65
2025-01-31	BUY	523	780.222*	759.78
2025-01-29	BUY	161	771.670*	758.94
2025-01-28	BUY	161	772.210*	758.66
2025-01-24	BUY	483	746.729*	758.68
2025-01-23	BUY	1,127	737.293*	759.15
2025-01-22	BUY	805	723.624*	759.96
2025-01-21	BUY	161	713.764*	761.04
2025-01-16	BUY	966	735.498*	764.67
2025-01-15	BUY	161	724.603*	765.70
2025-01-10	BUY	161	780.428*	766.00
2024-12-10	BUY	165	761.179*	766.25
2024-12-09	BUY	660	758.667*	766.49
2024-12-05	SELL	-330	780.839*	765.47 Profit of 252,606 on sale
2024-12-04	BUY	495	788.110*	764.69
2024-12-03	SELL	-825	773.311*	764.38 Profit of 630,616 on sale
2024-12-02	BUY	330	763.933*	764.40
2024-11-29	SELL	-3,232	753.030*	764.84 Profit of 2,471,953 on sale
2024-11-25	BUY	338	719.836*	769.11
2024-11-22	SELL	-169	718.549*	771.52 Profit of 130,387 on sale
2024-11-21	SELL	-169	713.462*	774.42 Profit of 130,877 on sale
2024-11-18	BUY	845	687.757*	787.96
2024-11-12	BUY	169	771.818*	788.97
2024-11-08	BUY	1,183	773.598*	790.58
2024-11-07	BUY	338	737.560*	794.65
2024-11-06	BUY	169	722.987*	800.63
2024-10-31	SELL	-2,194	764.279*	826.17 Profit of 1,812,623 on sale
2024-10-29	BUY	174	836.764*	832.18
2024-10-28	BUY	174	827.832*	833.05
2024-10-25	BUY	174	824.170*	835.27
2024-10-24	BUY	174	825.487*	838.54
2024-10-23	SELL	-348	838.283*	838.66 Profit of 291,855 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	432,038	935	1,319,853	32.7%
2025-09-18	547,818	126	1,290,147	42.5%
2025-09-17	437,337	427	1,166,204	37.5%
2025-09-16	532,698	1,829	1,463,374	36.4%
2025-09-15	424,979	701	1,071,487	39.7%
2025-09-12	267,121	172	826,802	32.3%
2025-09-11	249,803	1,484	850,461	29.4%
2025-09-10	415,442	1,025	989,008	42.0%
2025-09-09	559,805	667	1,270,800	44.1%
2025-09-08	856,018	4,682	1,937,447	44.2%
2025-09-05	679,276	1,050	1,405,239	48.3%
2025-09-04	337,491	53	982,751	34.3%
2025-09-03	214,691	496	766,157	28.0%
2025-09-02	430,477	2,977	1,131,908	38.0%
2025-08-29	357,538	602	889,509	40.2%
2025-08-28	433,687	1,099	1,113,568	38.9%
2025-08-27	860,715	6,009	1,681,353	51.2%
2025-08-26	1,548,460	12,105	2,955,348	52.4%
2025-08-25	566,454	3,586	1,323,249	42.8%
2025-08-22	749,615	1,957	1,460,713	51.3%
2025-08-21	651,639	223	1,570,067	41.5%
2025-08-20	679,554	2,698	1,870,241	36.3%
2025-08-19	787,909	935	2,788,740	28.3%
2025-08-18	756,143	1,095	1,727,603	43.8%
2025-08-15	1,814,721	836	3,422,260	53.0%
2025-08-14	1,852,940	5,382	3,602,829	51.4%
2025-08-13	1,254,225	3,473	2,774,100	45.2%
2025-08-12	990,110	3,190	2,845,896	34.8%
2025-08-11	1,290,063	1,615	5,196,302	24.8%
2025-08-08	2,448,706	300,870	6,239,830	39.2%
2025-08-07	4,197,951	489,618	10,364,294	40.5%
2025-08-06	440,144	1,120	1,811,262	24.3%
2025-08-05	331,460	921	993,178	33.4%
2025-08-04	474,905	1,408	1,273,995	37.3%
2025-08-01	530,569	7,139	1,882,098	28.2%
2025-07-31	882,506	3,670	2,110,030	41.8%
2025-07-30	745,614	392	1,827,435	40.8%
2025-07-29	1,081,849	571	2,607,245	41.5%
2025-07-28	304,841	7,460	1,004,032	30.4%
2025-07-25	365,417	265	1,055,273	34.6%
2025-07-24	321,799	762	1,167,147	27.6%
2025-07-23	485,719	3,471	1,044,919	46.5%
2025-07-22	241,098	3,036	874,717	27.6%
2025-07-21	418,014	854	1,180,445	35.4%
2025-07-18	623,498	651	1,225,333	50.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares S&P 500 EUR Hedged UCITS ETF (Acc)
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	IBCF(EUR) F
ETF Ticker	IUES.AS(EUR) CXE
ETF Ticker	IUSE.L(EUR) CXE
ETF Ticker	IUSE.MI(EUR) CXE
ETF Ticker	IUSEz(EUR) CXE
ETF Ticker	IUSE(EUR) ETF Plus